<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://my.spacstar.com/de/spac-ipo-news/inflection-point-acquisition-corp-viii-aktiensplit/</loc>
    <news:news>
      <news:publication>
        <news:name>SPACSTAR</news:name>
        <news:language>de</news:language>
      </news:publication>
      <news:publication_date>2026-09-30T21:19:23Z</news:publication_date>
      <news:title>Inflection Point Acquisition Corp. VIII Aktiensplit</news:title>
      <news:keywords>SPAC, IPO, Handel, Aktien, Optionsscheine</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://my.spacstar.com/de/spac-ipo-news/william-d-magwood-wird-newcleo-verwaltungsrat/</loc>
    <news:news>
      <news:publication>
        <news:name>SPACSTAR</news:name>
        <news:language>de</news:language>
      </news:publication>
      <news:publication_date>2026-09-30T20:28:09Z</news:publication_date>
      <news:title>William D. Magwood wird newcleo Verwaltungsrat</news:title>
      <news:keywords>newcleo, William D. Magwood, Kernenergie, Verwaltungsrat, Reaktor</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://my.spacstar.com/de/spac-ipo-news/vida-und-avant-kooperieren-fuer-ki-agenten-plattform/</loc>
    <news:news>
      <news:publication>
        <news:name>SPACSTAR</news:name>
        <news:language>de</news:language>
      </news:publication>
      <news:publication_date>2026-09-30T13:17:00Z</news:publication_date>
      <news:title>Vida und AVANT kooperieren für KI-Agenten-Plattform</news:title>
      <news:keywords>Vida, AVANT, KI-Agenten, künstliche Intelligenz, Partnerschaft</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://my.spacstar.com/de/spac-ipo-news/silexion-erster-patient-in-phase-2-3-studie-fuer-sil204/</loc>
    <news:news>
      <news:publication>
        <news:name>SPACSTAR</news:name>
        <news:language>de</news:language>
      </news:publication>
      <news:publication_date>2026-09-30T13:08:41Z</news:publication_date>
      <news:title>Silexion: Erster Patient in Phase-2/3-Studie für SIL204</news:title>
      <news:keywords>Silexion, SIL204, Bauchspeicheldrüsenkrebs, klinische Studie, RNAi</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://my.spacstar.com/de/spac-ipo-news/elmet-technologies-erhaelt-36m-dla-auftrag-fuer-luftfahrtmetalle/</loc>
    <news:news>
      <news:publication>
        <news:name>SPACSTAR</news:name>
        <news:language>de</news:language>
      </news:publication>
      <news:publication_date>2026-09-30T12:40:50Z</news:publication_date>
      <news:title>Elmet Technologies erhält 36M DLA-Auftrag für Luftfahrtmetalle</news:title>
      <news:keywords>Elmet Technologies, DLA Auftrag, Molybdän, Wolfram, Luftfahrtmaterialien</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://my.spacstar.com/de/spac-ipo-news/bluerock-acquisition-corp-ii-schliesst-172-5m-ipo-ab/</loc>
    <news:news>
      <news:publication>
        <news:name>SPACSTAR</news:name>
        <news:language>de</news:language>
      </news:publication>
      <news:publication_date>2026-09-29T20:26:01Z</news:publication_date>
      <news:title>Bluerock Acquisition Corp. II schließt 172,5M IPO ab</news:title>
      <news:keywords>IPO, SPAC, Bluerock Acquisition, Börsengang, Aktien</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://my.spacstar.com/de/spac-ipo-news/weshop-us-start-am-16-nov-mit-einkaeufen-aktien-verdienen/</loc>
    <news:news>
      <news:publication>
        <news:name>SPACSTAR</news:name>
        <news:language>de</news:language>
      </news:publication>
      <news:publication_date>2026-09-29T13:39:07Z</news:publication_date>
      <news:title>WeShop US-Start am 16. Nov: Mit Einkäufen Aktien verdienen</news:title>
      <news:keywords>WeShop, Shopping-App, Praemien, Aktien, NASDAQ: WSHP</news:keywords>
    </news:news>
  </url>
</urlset>
